Annals of Surgical Oncology

, Volume 22, Supplement 3, pp 1616–1616 | Cite as

Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

  • Toru Aoyama
  • Taiichi Kawabe
  • Hirohito Fujikawa
  • Tsutomu Hayashi
  • Takanobu Yamada
  • Kazuhito Tsuchida
  • Norio Yukawa
  • Takashi Oshima
  • Yasushi Rino
  • Munetaka Masuda
  • Takashi Ogata
  • Haruhiko Cho
  • Takaki Yoshikawa
Erratum
  • 560 Downloads

Erratum to: Ann Surg Oncol DOI 10.1245/s10434-014-4296-z

In the original article there was an error in Fig. 3. Following is the corrected figure:
Fig. 3

Comparison of the treatment continuation rates between patients who experienced a lean body-mass loss of <5 % and those who lost more than 5 % of their lean body mass

Copyright information

© Society of Surgical Oncology 2015

Authors and Affiliations

  • Toru Aoyama
    • 1
    • 2
  • Taiichi Kawabe
    • 1
    • 2
  • Hirohito Fujikawa
    • 1
    • 2
  • Tsutomu Hayashi
    • 1
    • 2
  • Takanobu Yamada
    • 1
    • 2
  • Kazuhito Tsuchida
    • 1
    • 2
  • Norio Yukawa
    • 2
  • Takashi Oshima
    • 2
  • Yasushi Rino
    • 2
  • Munetaka Masuda
    • 2
  • Takashi Ogata
    • 1
  • Haruhiko Cho
    • 1
  • Takaki Yoshikawa
    • 1
    • 2
  1. 1.Department of Gastrointestinal SurgeryKanagawa Cancer CenterYokohamaJapan
  2. 2.Department of SurgeryYokohama City UniversityYokohamaJapan

Personalised recommendations